GTHX - G1 Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.4B
Enterprise Value 31.07B
Trailing P/E N/A
Forward P/E 1-9.12
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.47
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-10.21

Trading Information

Stock Price History

Beta (3Y Monthly) 2.65
52-Week Change 3-30.30%
S&P500 52-Week Change 3-0.33%
52 Week High 369.57
52 Week Low 313.87
50-Day Moving Average 328.05
200-Day Moving Average 321.98

Share Statistics

Avg Vol (3 month) 3475.18k
Avg Vol (10 day) 3611.98k
Shares Outstanding 537.47M
Float 27.85M
% Held by Insiders 117.81%
% Held by Institutions 189.86%
Shares Short (Jul 31, 2019) 43.93M
Short Ratio (Jul 31, 2019) 411.96
Short % of Float (Jul 31, 2019) 416.23%
Short % of Shares Outstanding (Jul 31, 2019) 410.46%
Shares Short (prior month Jun 28, 2019) 43.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.22%
Return on Equity (ttm)-40.33%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-70.68M
EBITDA -105.14M
Net Income Avi to Common (ttm)-98.65M
Diluted EPS (ttm)-2.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)324.91M
Total Cash Per Share (mrq)8.66
Total Debt (mrq)1.46M
Total Debt/Equity (mrq)0.47
Current Ratio (mrq)18.35
Book Value Per Share (mrq)8.34

Cash Flow Statement

Operating Cash Flow (ttm)-82.47M
Levered Free Cash Flow (ttm)-50.64M